What is Interpace Biosciences's P/E Ratio?

Interpace Biosciences's trailing twelve month (TTM) P/E ratio is 3.13.

Interpace Biosciences's annual P/E ratio as of today is 5.81.

Interpace Biosciences's quarterly P/E ratio is 0.57.

Understanding the P/E Ratio

The Price-to-Earnings (P/E) ratio is a valuation ratio of a company's current share price compared to its earnings per share (EPS). The P/E ratio is calculated as:

P/E Ratio = Current Share Price / Earnings Per Share (EPS)

Related Metrics

The Price-to-Book (P/B) ratio compares a company's market value to its book value, giving investors an idea of whether a stock is over- or undervalued based on the company's assets and liabilities.

Interpace Biosciences's annual P/B Ratio as of today is -0.31.

The Price-to-Sales (P/S) ratio evaluates a company's stock price in relation to its revenue, offering a view on how much investors are willing to pay per dollar of sales.

Interpace Biosciences's annual P/S Ratio as of today is 0.12.